Foscarnet: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
(warnings)
imported>David E. Volk
No edit summary
Line 16: Line 16:
}}
}}


'''Foscarnet''' is an [[antiviral drug]] used to treat [[retinitis]] due to [[cytomegalovirus]] (CMV) and acyclovir-resistant [[herpes simplex virus]] (HSV-1 & HSV-2) infections, particularly in patients with compromised immune systems often associated with [[HIV]]/[[AIDS]].   
'''Foscarnet''' is an [[antiviral drug]] used to treat [[retinitis]] due to [[cytomegalovirus]] (CMV) and acyclovir-resistant [[herpes simplex virus]] (HSV-1 & HSV-2) infections in patients with compromised immune systems, often associated with [[HIV]]/[[AIDS]].  Foscarnet is usually injected, as the trisodium salt, due to poor absorption.  
 
== Chemistry ==
Foscarnet is a [[carboxylic acid]]-based organic mimic of the natural inorganic compound [[pyrophosphate]].  The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH<sub>3</sub>O<sub>5</sub>P, giving it a molecular mass of 126.0053 g/mol.  Being already phosphorylated, foscarnet does not need to be phosphorylated to become active.  Becuase of this, viral strains resistant to [[acyclovir]] or [[ganciclovir]], associated with thymidine kinase deficiency, may be treatable with foscarnet.  Foscarnet and related compounds, like [[phosphonoacetic acid]] (PAA), can be synthesized by reacting chloroformic acid esters with phosphites<ref>{{cite journal | author=Noren, Helgstrand, Johansson, Misiorny and Stening | title=Synthesis of esters of phosphonoformic acid and their antiherpes activity| journal=J. Med. Chem. |volume = 26 |issue=2 |pages=264-270 |year=1983|doi=|10.1021/jm00356a028 |url=http://pubs.acs.org/cgi-bin/archive.cgi/jmcmar/1983/26/i02/pdf/jm00356a028.pdf}}</ref>, typical of an [[Arbuzov reaction]].


== Mechanism of action ==
== Mechanism of action ==
Line 26: Line 23:
== Warnings ==
== Warnings ==
Renal toxicity and impairment is a concern when using foscarnet.  Associated changes in mineral and electrolyte concentrations may also cause seizures, so hydration must be ensured and serium creatinine levels monitored.
Renal toxicity and impairment is a concern when using foscarnet.  Associated changes in mineral and electrolyte concentrations may also cause seizures, so hydration must be ensured and serium creatinine levels monitored.
== Chemistry ==
Foscarnet is a [[carboxylic acid]]-based organic mimic of the natural inorganic compound [[pyrophosphate]].  The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH<sub>3</sub>O<sub>5</sub>P, giving it a molecular mass of 126.0053 g/mol.  Being already phosphorylated, foscarnet does not need to be phosphorylated to become active.  Becuase of this, viral strains resistant to [[acyclovir]] or [[ganciclovir]], associated with thymidine kinase deficiency, may be treatable with foscarnet.  Foscarnet and related compounds, like [[phosphonoacetic acid]] (PAA), can be synthesized by reacting chloroformic acid esters with phosphites<ref>{{cite journal | author=Noren, Helgstrand, Johansson, Misiorny and Stening | title=Synthesis of esters of phosphonoformic acid and their antiherpes activity| journal=J. Med. Chem. |volume = 26 |issue=2 |pages=264-270 |year=1983|doi=|10.1021/jm00356a028 |url=http://pubs.acs.org/cgi-bin/archive.cgi/jmcmar/1983/26/i02/pdf/jm00356a028.pdf}}</ref>, typical of an [[Arbuzov reaction]].


== Synonyms and brand names ==
== Synonyms and brand names ==

Revision as of 14:34, 28 March 2008

This article is developed but not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable, developed Main Article is subject to a disclaimer.
Foscarnet.jpg
foscarnet
IUPAC name: phosphonoformic acid
Synonyms: see list below
Formula: CH3O5P

 Uses: treatment of CMV retinitis, herpes and HIV.

 Properties: antiviral agent

 Hazards: see drug interactions

Mass (g/mol): CAS #:
126.0053 63585-09-1


Foscarnet is an antiviral drug used to treat retinitis due to cytomegalovirus (CMV) and acyclovir-resistant herpes simplex virus (HSV-1 & HSV-2) infections in patients with compromised immune systems, often associated with HIV/AIDS. Foscarnet is usually injected, as the trisodium salt, due to poor absorption.

Mechanism of action

Foscarnet binds to pyrophosphate binding sites of DNA polymerases and thus inhibits the production of viral DNA by blocking the energy source (pyrophosphate) from reaching the viral polymerases. Cellular DNA polymerases are not effected by the dosages at foscarnet is taken.

Warnings

Renal toxicity and impairment is a concern when using foscarnet. Associated changes in mineral and electrolyte concentrations may also cause seizures, so hydration must be ensured and serium creatinine levels monitored.

Chemistry

Foscarnet is a carboxylic acid-based organic mimic of the natural inorganic compound pyrophosphate. The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH3O5P, giving it a molecular mass of 126.0053 g/mol. Being already phosphorylated, foscarnet does not need to be phosphorylated to become active. Becuase of this, viral strains resistant to acyclovir or ganciclovir, associated with thymidine kinase deficiency, may be treatable with foscarnet. Foscarnet and related compounds, like phosphonoacetic acid (PAA), can be synthesized by reacting chloroformic acid esters with phosphites[1], typical of an Arbuzov reaction.

Synonyms and brand names

Synonyms

  • Carboxyphosphonic acid
  • Dihydroxyphosphinecarboxylic acid oxide
  • Foscarnet sodium
  • Forscarnet sodium
  • hydroxycarbonyl phosponic acid
  • PFA
  • Phgosphonocarboxylic acid
  • Phosphonoformate
  • Phosphonoformic acid

Brand names

  • Foscarmet®
  • Foscavir®
  • Triapten®

External links

References

  1. Noren, Helgstrand, Johansson, Misiorny and Stening (1983). "Synthesis of esters of phosphonoformic acid and their antiherpes activity". J. Med. Chem. 26 (2): 264-270. [e]